Ignite Creation Date:
2024-05-06 @ 9:40 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03042611
Status:
COMPLETED
Last Update Posted:
2022-07-08
First Post:
2017-01-24
Brief Title:
A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer
Sponsor:
Elevar Therapeutics
Organization:
Elevar Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-23
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-24
First Submit QC Date:
February 2 2017
Study First Post Date:
2017-02-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-07-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-15
Last Update Post Date:
2022-07-08
Last Update Post Date Type:
ACTUAL